Powered by
-
ALNY Stock Chart
Historical ALNY Prices
Alnylam Pharmaceut Stock Analysis
Rating: Sell
Total Grade: D
Analysis Breakdown
| ALNY Stock Grade: | D |
| Fundamental Grade: | C |
| Quantitative Grade: | D |
| ALNY Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | C |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| ALNY Financial Information | |
| Sales Growth: | A |
| Operating Margin Growth: | C |
| Cash Flow: | F |
| Return on Equity: | F |
Alnylam Pharmaceut Stock: Weekly View
| This Week: | D |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | D |
ALNY Stock predictions, Articles, and Alnylam Pharmaceut News
- From InvestorPlace
- From the Web
-
7 Lucrative Biotech Stocks With Up to 300% Upside - September 6, 2018
These seven biotech stocks all have support from Wall Street's top-performing analysts and have eye-watering upside potential ahead. Continue…
-
8 Undervalued Biotech Stocks to Watch - August 20, 2018
Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names. Continue…
-
Alnylam Pharmaceuticals (ALNY) a Buy on Healthy Quant Score - November 6, 2017
Currently, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month. Continue…
-
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Soars on Drug Breakthrough - September 20, 2017
Alnylam Pharmaceuticals (ALNY) shares skyrocketed more than 50% on Wednesday morning on the news that the company's latest drug impressed. Continue…
-
4 Biotech Stocks That More Than Doubled This Year - September 5, 2017
The biotech sector has been witnessing an uptrend this year with impressive performance in both the quarters. Shares of quite a few companies have more than dou... Continue…
-
3 Pivotal Drug Trials to Watch for Explosive Potential - June 29, 2017
Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon. Continue…
-
5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now - April 12, 2017
Paris, France based Sanofi (SNY) is a global healthcare company possessing a diversified product portfolio. Continue…
-
Is Now the Time to Buy Into These 5 Biotech ETFs? - March 14, 2017
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out Continue…
-
Why Alnylam Pharmaceuticals, Inc. Stock Is a 2017 Winner (ALNY) - January 9, 2017
The pharmaceutical sector is well known as one of the most volatile and lucrative stock market sectors, and we've found a winner for 2017... Continue…
-
40 Biotechnology Stocks to Sell Now - December 12, 2016
This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Continue…
